LLY
Eli Lilly and Company
- Total assets, 2025
- $112.5B
- YoY, 2025
- +42.9%
- 5-year CAGR
- +19.3%
- 10-year CAGR
- +12.2%
Total assets
Total assets by fiscal year
| Period | Total assets | YoY |
|---|---|---|
| 2025 | $112.5B | +42.9% |
| 2024 | $78.7B | +23.0% |
| 2023 | $64.0B | +29.3% |
| 2022 | $49.5B | +1.4% |
| 2021 | $48.8B | +4.7% |
| 2020 | $46.6B | +18.7% |
| 2019 | $39.3B | −10.5% |
| 2018 | $43.9B | −2.4% |
| 2017 | $45.0B | +15.9% |
| 2016 | $38.8B | +9.1% |
| 2015 | $35.6B | −2.0% |
| 2014 | $36.3B | +3.0% |
| 2013 | $35.2B | +2.5% |
| 2012 | $34.4B | +2.2% |
| 2011 | $33.7B | +8.6% |
| 2010 | $31.0B | +12.9% |
| 2009 | $27.5B | −6.0% |
| 2008 | $29.2B | — |